Cardiovascular Division, Cardio-Oncology Center of Excellence, Washington University School of Medicine, 660 South Euclid Avenue, Box 8086, St. Louis, MO, 63110-1093, USA.
Department of Cardiology, University Hospital Heidelberg, Heidelberg, Germany.
Int J Cardiovasc Imaging. 2021 Oct;37(10):3003-3017. doi: 10.1007/s10554-021-02271-7. Epub 2021 May 12.
The purpose of this review is to provide an overview of the essential role that cardiovascular magnetic resonance (CMR) has in the field of cardio-oncology. Recent findings: CMR has been increasingly used for early identification of cancer therapy related cardiac dysfunction (CTRCD) due to its precision in detecting subtle changes in cardiac function and for myocardial tissue characterization. Summary: CMR is able to identify subclinical CTRCD in patients receiving potentially cardiotoxic chemotherapy and guide initiation of cardio protective therapy. Multiparametric analysis with myocardial strain, tissue characterization play a critical role in understanding important clinical questions in cardio-oncology.
本文旨在概述心血管磁共振（CMR）在肿瘤心脏病学领域的重要作用。最近的发现：由于 CMR 在检测心脏功能细微变化方面的精确性，以及在心肌组织特征描述方面的优势，它已越来越多地用于早期识别癌症治疗相关的心脏功能障碍（CTRCD）。 总结：CMR 能够在接受潜在心脏毒性化疗的患者中识别亚临床 CTRCD，并指导心脏保护治疗的开始。心肌应变的多参数分析、组织特征描述在理解肿瘤心脏病学中的重要临床问题方面发挥着关键作用。
